Fortress Biotech, Inc. (NASDAQ:FBIOP – Get Free Report)’s share price passed below its two hundred day moving average during trading on Tuesday. The stock has a two hundred day moving average of $16.15 and traded as low as $15.78. Fortress Biotech shares last traded at $16.01, with a volume of 23,560 shares.
Fortress Biotech Stock Performance
The company has a 50 day moving average price of $17.52 and a 200 day moving average price of $16.20.
About Fortress Biotech
Fortress Biotech, Inc is a biopharmaceutical company focused on developing and commercializing medicines for serious and underserved diseases. Its research and development activities span oncology, immunology, infectious diseases, rare diseases and dermatology, with programs developed internally and through a network of subsidiary companies and strategic partners.
The company’s portfolio has included biologic therapies, small-molecule medicines and gene therapies. Fortress has supported the development of products such as cosibelimab, an investigational monoclonal antibody targeting PD-L1, as well as dermatology treatments developed through its Journey Medical subsidiary.
Featured Stories
- Five stocks we like better than Fortress Biotech
- Phillips 66 Posts Strong Earnings But the Stock Doesn’t Care
- NXP Semiconductors Falls After Strong Earnings—Is the Sell-Off Overdone?
- GE Vernova’s Reservations Are Turning Into Real Orders—But the Market Still Wants More.
- Where’s the Beef? Trian-Led Buyout Proposal Values Wendy’s at $1.4B, But Is It Enough?
Receive News & Ratings for Fortress Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fortress Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
-limited-logo-1200x675.png){kind=logo}